Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eeva Moilanen

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Basic & Clinical Pharmacology & Toxicology|November 30, 2013
Two faces of inflammation: an immunopharmacological viewEeva Moilanen
Basic & Clinical Pharmacology & Toxicology|February 21, 2009
Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritisRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|October 12, 2013
Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug targetRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|August 19, 2009
Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritisRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|September 25, 2024
Macrophage and chondrocyte phenotypes in inflammationAntti Pemmari, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|November 2, 2007
Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing processKatriina Vuolteenaho, Teemu Moilanen, Eeva Moilanen
European Journal of Pharmacology|July 30, 2002
Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell linesMari Hämäläinen, Aleksi Lahti, Eeva Moilanen
Current Drug Targets. Inflammation and Allergy|August 17, 2005
Pharmacological regulation of human eosinophil apoptosisHannu Kankaanranta, Eeva Moilanen, Xianzhi Zhang
Basic & Clinical Pharmacology & Toxicology|October 22, 2013
Leptin - a link between obesity and osteoarthritis. applications for prevention and treatmentKatriina Vuolteenaho, Anna Koskinen, Eeva Moilanen
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 17, 2017
Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cellsTiina Keränen, Eeva Moilanen, Riku Korhonen
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Basic & Clinical Pharmacology & Toxicology|November 30, 2013
Two faces of inflammation: an immunopharmacological viewEeva Moilanen
Basic & Clinical Pharmacology & Toxicology|February 21, 2009
Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritisRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|October 12, 2013
Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug targetRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|August 19, 2009
Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritisRiku Korhonen, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|September 25, 2024
Macrophage and chondrocyte phenotypes in inflammationAntti Pemmari, Eeva Moilanen
Basic & Clinical Pharmacology & Toxicology|November 2, 2007
Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing processKatriina Vuolteenaho, Teemu Moilanen, Eeva Moilanen
European Journal of Pharmacology|July 30, 2002
Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell linesMari Hämäläinen, Aleksi Lahti, Eeva Moilanen
Current Drug Targets. Inflammation and Allergy|August 17, 2005
Pharmacological regulation of human eosinophil apoptosisHannu Kankaanranta, Eeva Moilanen, Xianzhi Zhang
Basic & Clinical Pharmacology & Toxicology|October 22, 2013
Leptin - a link between obesity and osteoarthritis. applications for prevention and treatmentKatriina Vuolteenaho, Anna Koskinen, Eeva Moilanen
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 17, 2017
Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cellsTiina Keränen, Eeva Moilanen, Riku Korhonen
Pageof 26